687 related articles for article (PubMed ID: 18222209)
1. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
2. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
3. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
5. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma.
Maish MS; DeMeester SR
Ann Thorac Surg; 2004 Nov; 78(5):1777-82. PubMed ID: 15511474
[TBL] [Abstract][Full Text] [Related]
8. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
Peyre CG; DeMeester SR; Rizzetto C; Bansal N; Tang AL; Ayazi S; Leers JM; Lipham JC; Hagen JA; DeMeester TR
Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
[TBL] [Abstract][Full Text] [Related]
9. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
Gilbert S; Jobe BA
Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
Pech O; Ell C
Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
[TBL] [Abstract][Full Text] [Related]
12. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
Donnellan F; Harewood GC; Patchett SE
Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
[No Abstract] [Full Text] [Related]
13. Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus.
DeMeester SR
Semin Thorac Cardiovasc Surg; 2005; 17(4):320-5. PubMed ID: 16428038
[TBL] [Abstract][Full Text] [Related]
14. Intramucosal esophageal cancer and high-grade dysplasia: which treatment frame the debate.
Oelschlager BK
J Gastrointest Surg; 2009 Jul; 13(7):1169-71. PubMed ID: 19322615
[No Abstract] [Full Text] [Related]
15. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
Luna RA; Gilbert E; Hunter JG
Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
[TBL] [Abstract][Full Text] [Related]
17. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
18. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
19. Dysplasia in Barrett's esophagus: limitations of current management strategies.
Spechler SJ
Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
[TBL] [Abstract][Full Text] [Related]
20. Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.
Schembre DB
J Gastrointest Surg; 2009 Jul; 13(7):1172-8. PubMed ID: 19322616
[No Abstract] [Full Text] [Related]
[Next] [New Search]